Transplantation Immunology

移植免疫学

基本信息

项目摘要

DESCRIPTION (provided by applicant): This is an application for partial funding of a conference on "Transplantation Immunology" that will be held under the auspices of FASEB in New Haven, Connecticut, July 13-18, 2008. This conference follows the successful 2002, 2004 and 2006 FASEB Summer Research Conferences on the same topic held at Saxton's River Vermont and Snowmass, Colorado. The 2008 conference will target the most important recent developments in molecular and cellular aspects of innate and adaptive immunology, and technologic advances that have direct relevance to improved understanding of the mechanistic basis of transplant rejection and tolerance. Equally significant, are the implications of these findings for the development of improved therapies of cell and organ graft rejection, which may lead ultimately, to the consistent achievement of clinical transplantation tolerance. Emphasis will be placed on the most recent insights and the meeting will be divided into 8 sessions that will be devoted to 1) Innate Immune Cells 2) Dendritic Cells; 3) Immune Cell Migration and Imaging; 4) T cell Activation and Memory; 5) Regulatory Cells; 6) Islet Transplantation and Cell Therapy; 7) B cells, Antibodies in Allo- and Xeno-transplantation and 8) Immunological Monitoring. An important aspect of this conference will be the interaction between scientists with expertise in basic immunology and molecular genetics/biology and transplantation scientists and clinicians. Approximately 80-100 participants will be selected from amongst those investigators most likely to share the most recent new knowledge and contribute to stimulating exchange of ideas/concepts. The organizers have continually strived to include women, minorities and disabled individuals at each step of planning/program development. Speakers will be those who have made the most significant recent contributions. There will be one poster presentation session. The conference will also provide an important forum for dialogue between contributors from a broad range of subspecialties. The aggregate result should be an overview and integrated perspective/consensus of this rapidly moving field of applied biomedical science. An important goal will be the evaluation of future research directions, as well as critical appraisal of contemporary "cutting edge" research in Transplantation Immunology. The 2008 FASEB Summer Research Conference on Transplantation Immunology will target the most important recent developments in molecular and cellular aspects of innate and adaptive immunology, and technologic advances that have direct relevance to improved understanding of the mechanistic basis of transplant rejection and tolerance. An important aspect of this conference will be the close interaction between scientists with expertise in basic immunology and molecular genetics/biology and transplantation scientists and clinicians, as well as the trainees. An important goal will be the evaluation of future research directions, as well as critical appraisal of contemporary "cutting edge" research in Transplantation Immunology.
描述(由申请人提供): 这是一个关于“移植免疫学”会议的部分资金申请,该会议将于2008年7月13日至18日在康涅狄格州纽黑文市举行,由FASEB主持。本次会议是继2002年、2004年和2006年在萨克斯顿的佛蒙特河和科罗拉多的斯诺马斯举行的关于同一主题的FASEB夏季研究会议之后的又一次成功会议。2008年会议将针对先天和适应性免疫学的分子和细胞方面的最重要的最新发展,以及与提高对移植排斥和耐受的机制基础的理解直接相关的技术进步。同样重要的是,这些发现对开发细胞和器官移植排斥的改进疗法的意义,这可能最终导致临床移植耐受的一致实现。重点将放在最新的见解,会议将分为8个会议,将致力于1)先天免疫细胞2)树突状细胞; 3)免疫细胞迁移和成像; 4)T细胞活化和记忆; 5)调节细胞; 6)胰岛移植和细胞治疗; 7)B细胞,同种异体和异种移植中的抗体和8)免疫监测。本次会议的一个重要方面将是具有基础免疫学和分子遗传学/生物学专业知识的科学家与移植科学家和临床医生之间的互动。将从最有可能分享最新知识并有助于促进思想/概念交流的研究者中选出约80-100名参与者。组织者不断努力将妇女、少数民族和残疾人纳入规划/方案制定的每一步。发言者将是那些最近作出最重大贡献的人。将有一个海报展示会。会议还将提供一个重要的论坛,供来自广泛的子专业的贡献者之间进行对话。总的结果应该是应用生物医学科学这一快速发展领域的概述和综合观点/共识。一个重要的目标将是评估未来的研究方向,以及在移植免疫学的当代“前沿”研究的批判性评价。2008年FASEB夏季移植免疫学研究会议将针对先天和适应性免疫学的分子和细胞方面的最重要的最新发展,以及与提高对移植排斥和耐受机制基础的理解直接相关的技术进步。本次会议的一个重要方面将是具有基础免疫学和分子遗传学/生物学专业知识的科学家与移植科学家和临床医生以及受训人员之间的密切互动。一个重要的目标将是评估未来的研究方向,以及在移植免疫学的当代“前沿”研究的批判性评价。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Anita S Chong其他文献

Anita S Chong的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Anita S Chong', 18)}}的其他基金

Intrarenal B cells in acute kidney allograft rejection
肾内 B 细胞在急性同种肾移植排斥反应中的作用
  • 批准号:
    10543172
  • 财政年份:
    2020
  • 资助金额:
    $ 1.5万
  • 项目类别:
Intrarenal B cells in acute kidney allograft rejection
肾内 B 细胞在急性同种肾移植排斥反应中的作用
  • 批准号:
    9980656
  • 财政年份:
    2020
  • 资助金额:
    $ 1.5万
  • 项目类别:
Intrarenal B cells in acute kidney allograft rejection
肾内 B 细胞在急性同种肾移植排斥反应中的作用
  • 批准号:
    10329990
  • 财政年份:
    2020
  • 资助金额:
    $ 1.5万
  • 项目类别:
Deconstructing B cell transplantation tolerance
解构B细胞移植耐受性
  • 批准号:
    10455472
  • 财政年份:
    2019
  • 资助金额:
    $ 1.5万
  • 项目类别:
Deconstructing B cell transplantation tolerance
解构B细胞移植耐受性
  • 批准号:
    10216969
  • 财政年份:
    2019
  • 资助金额:
    $ 1.5万
  • 项目类别:
Supramolecular nanofiber vaccines
超分子纳米纤维疫苗
  • 批准号:
    8911035
  • 财政年份:
    2015
  • 资助金额:
    $ 1.5万
  • 项目类别:
Supramolecular nanofiber vaccines
超分子纳米纤维疫苗
  • 批准号:
    9402045
  • 财政年份:
    2015
  • 资助金额:
    $ 1.5万
  • 项目类别:
Supramolecular nanofiber vaccines
超分子纳米纤维疫苗
  • 批准号:
    9217567
  • 财政年份:
    2015
  • 资助金额:
    $ 1.5万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    8512663
  • 财政年份:
    2013
  • 资助金额:
    $ 1.5万
  • 项目类别:
Impact of Infections on the Stability of Established Tolerance
感染对既定耐受稳定性的影响
  • 批准号:
    8512661
  • 财政年份:
    2013
  • 资助金额:
    $ 1.5万
  • 项目类别:

相似海外基金

University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
  • 批准号:
    10073243
  • 财政年份:
    2024
  • 资助金额:
    $ 1.5万
  • 项目类别:
    Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
  • 批准号:
    10752129
  • 财政年份:
    2024
  • 资助金额:
    $ 1.5万
  • 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
  • 批准号:
    2339201
  • 财政年份:
    2024
  • 资助金额:
    $ 1.5万
  • 项目类别:
    Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
  • 批准号:
    MR/Y008693/1
  • 财政年份:
    2024
  • 资助金额:
    $ 1.5万
  • 项目类别:
    Research Grant
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
  • 批准号:
    23K14783
  • 财政年份:
    2023
  • 资助金额:
    $ 1.5万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
  • 批准号:
    23KJ0394
  • 财政年份:
    2023
  • 资助金额:
    $ 1.5万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
  • 批准号:
    10076445
  • 财政年份:
    2023
  • 资助金额:
    $ 1.5万
  • 项目类别:
    Grant for R&D
PLA2G2D Antibodies for Cancer Immunotherapy
用于癌症免疫治疗的 PLA2G2D 抗体
  • 批准号:
    10699504
  • 财政年份:
    2023
  • 资助金额:
    $ 1.5万
  • 项目类别:
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
  • 批准号:
    10491642
  • 财政年份:
    2023
  • 资助金额:
    $ 1.5万
  • 项目类别:
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface
新型免疫原可引发针对血凝素头三聚体界面的广泛交叉反应抗体
  • 批准号:
    10782567
  • 财政年份:
    2023
  • 资助金额:
    $ 1.5万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了